Raw materials for biological processes

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD, used as an immunosuppressant agent.An inhibitor of Cox-2 and tyrosine kinase.

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD, used as an immunosuppressant agent.An inhibitor of Cox-2 and tyrosine kinase.

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD, used as an immunosuppressant agent.An inhibitor of Cox-2 and tyrosine kinase.

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD, used as an immunosuppressant agent.An inhibitor of Cox-2 and tyrosine kinase.

Leflunomide is a pyrimidine synthesis inhibitor belonging to the DMARD, used as an immunosuppressant agent.An inhibitor of Cox-2 and tyrosine kinase.

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium

Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium

Levetiracetam is an antiepileptic which displays distinctive properties from conventional antiepileptic drugs. Displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Binds synaptic vesicle

Levetiracetam is an antiepileptic which displays distinctive properties from conventional antiepileptic drugs. Displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Binds synaptic vesicle